Close Menu

NEW YORK ─ Ahrensburg, Germany-based Abviris, the developer of a lateral flow test for cancer detection, said on Tuesday that it has raised almost €2 million ($2.4 million) in financing to expand its business.

Current investor High-Tech Gründerfonds, a venture capital investment firm based in Bonn, Germany, was the "the most significant" investor in the financing, a company representative said in an email, declining to name the other investors in the financing.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Apr
29
Sponsored by
Co-Diagnostics

Join Dr. Heather Fehling, Chief Scientific Officer at Clinical Reference Labs (CRL), as she provides some insights regarding the future applications of PCR testing.